Skip to content

Study on the Effect of Vagus Nerve Stimulation on Postoperative Sleep Quality and Recovery in Patients Undergoing Gynecological Laparoscopic Surgery

A study on the effect of percutaneous auricular vagus nerve stimulation on postoperative sleep quality and recovery in patients undergoing gynecological laparoscopic surgery: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116242
Enrollment
Unknown
Registered
2026-01-07
Start date
2026-01-12
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disorder

Interventions

Control group:On the day before surgery through postoperative day 2 (a total of 4 days), two sham stimulation interventions were performed daily at 08:00 and 20:00, following the same protocol as the
however, only a brief sensation of stimulation at 30 Hz and 200 µs was delivered at the start, after which the device was turned off, and the intervention concluded 40 minutes later. No actual vagus n
Trial group:From the day before surgery through postoperative day 2 (a total of 4 days), two transcutaneous auricular vagus nerve stimulation (taVNS) interventions were performed daily at 08:00 and 20

Sponsors

The First People's Hospital of Zunyi
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) physical status I - III. 2. Age >=18 years and ==1.5 hours and =<4.0 hours. 5. No severe disease in other systems or organs. 6. Subject voluntarily participates in the study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.During the percutaneous stimulation of the auricular vagus nerve, the stimulation site showed signs of redness, swelling and infection, or there was damage to the skin of the ear. 2.Patients who had tinnitus, visual or auditory impairments, or arrhythmia before the operation, and patients who had implanted medical devices (such as cardiac pacemakers). 3.Body mass index > 35 kg/m^². 4.Those with a history of major surgeries or patients who have undergone cardiopulmonary resuscitation. 5.History of neurological or mental disorders; chronic pain or stubborn insomnia; history of drug abuse; severe cardiovascular diseases or serious disorders of liver and kidney functions. 6.Unwilling to participate or unable to complete the trial consecutively. 7.Other reasons why individuals are not suitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Richards-Campbell Sleep Questionnaire;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Actigraphy;Visual Analogue Scale?;Intake, Feeling nauseated, Emesis, Exam, and Duration of symptoms score;Hamilton Anxiety Rating Scale;Other scales include the Quality of Recovery-15 (QoR-15), Kristensen Fatigue Rating Scale, Intraoperative and Postoperative Fatigue Scale (ICFS), and the Hamilton Depression Rating Scale (HAMD).;

Countries

China

Contacts

Public ContactLi Biao

The First People's Hospital of Zunyi

2313550601@qq.com+86 10 23235901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026